Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine plus capecitabine vs capecitabine in metastatic breast cancer
CTR20131773Phase 3Suspended
- Sponsor
- Pierre Fabre Laboratories
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vinflunine in breast cancer, sponsored by Pierre Fabre Laboratories. Started Apr 2014; status: suspended.
02
Drugs
vinflunine
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20131773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131773.